Trial Profile
RGB-10 Phase 3 study -A comparative study to evaluate the similarity of RGB-10 to Forteo in patients with osteoporosis at high risk of fracture-
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Mar 2020
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Calcium; Vitamin D
- Indications Fracture; Osteoporosis
- Focus Therapeutic Use
- Sponsors Mochida Pharmaceutical
- 04 Sep 2018 New trial record